Knock-out-Zertifikate finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
25 Ergebnisse
| MB01N9 |  | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 43,403 | 56,350 | 1,215 | 76,360 % | - | Morgan Stanley | |
| MB0VSK | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 54,007 | 70,120 | 1,283 | 70,584 % | - | Morgan Stanley | |
| MB3QK3 | | Axsome Therapeutics Inc./Faktor/Long [4]/MS | - | - | call | Axsome Therapeutics Inc. | 180,850 | 180,850 | 4,026 | 24,131 % | - | Morgan Stanley | |
| MB6NLB | | Axsome Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Axsome Therapeutics Inc. | 192,907 | 192,907 | 5,065 | 19,073 % | - | Morgan Stanley | |
| MD6HV2 | | Axsome Therapeutics Inc./Faktor/Long [3]/MS | - | - | call | Axsome Therapeutics Inc. | 160,756 | 160,756 | 3,006 | 32,560 % | - | Morgan Stanley | |
| ME6CR6 | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 58,258 | 75,640 | 1,315 | 68,268 % | - | Morgan Stanley | |
| MG23NX | | Axsome Therapeutics Inc./Faktor/Long [6]/MS | - | - | call | Axsome Therapeutics Inc. | 200,970 | 200,970 | 6,155 | 15,690 % | - | Morgan Stanley | |
| MG2XYQ | | Axsome Therapeutics Inc./Faktor/Long [4]/MS | - | - | call | Axsome Therapeutics Inc. | 180,873 | 180,873 | 4,026 | 24,121 % | - | Morgan Stanley | |
| MJ42F0 | | Axsome Therapeutics Inc./Faktor/Long [2]/MS | - | - | call | Axsome Therapeutics Inc. | 120,582 | 120,582 | 1,997 | 49,414 % | - | Morgan Stanley | |
| MJ7VDB | | Axsome Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Axsome Therapeutics Inc. | 192,931 | 192,931 | 5,055 | 19,062 % | - | Morgan Stanley | |
| MJ8AZ2 | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 70,219 | 91,170 | 1,406 | 61,753 % | - | Morgan Stanley | |
| MM1NMC | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 83,512 | 108,420 | 1,525 | 54,516 % | - | Morgan Stanley | |
| MM65CU | | Axsome Therapeutics Inc./Faktor/Short [3]/MS | - | - | put | Axsome Therapeutics Inc. | 321,310 | 321,310 | 2,845 | 34,795 % | - | Morgan Stanley | |
| MM66R0 | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 98,349 | 127,690 | 1,677 | 46,432 % | - | Morgan Stanley | |
| MM8V6F | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 113,603 | 147,490 | 1,889 | 38,126 % | - | Morgan Stanley | |
| MN121F | | Axsome Therapeutics Inc./Faktor/Short [2]/MS | - | - | put | Axsome Therapeutics Inc. | 361,474 | 361,474 | 1,930 | 51,644 % | - | Morgan Stanley | |
| MN34K8 | | Axsome Therapeutics Inc./Faktor/Short [5]/MS | - | - | put | Axsome Therapeutics Inc. | 289,179 | 289,179 | 4,649 | 21,315 % | - | Morgan Stanley | |
| MN3YJ7 | | Axsome Therapeutics Inc./Faktor/Short [4]/MS | - | - | put | Axsome Therapeutics Inc. | 301,228 | 301,228 | - | 26,370 % | - | Morgan Stanley | |
| MN7S6M | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 125,967 | 163,540 | 2,074 | 31,392 % | - | Morgan Stanley | |
| MN95J8 | | Axsome Therapeutics Inc./KO/Call [endlos]/MS | - | - | call | Axsome Therapeutics Inc. | 156,712 | 203,460 | 2,871 | 14,645 % | - | Morgan Stanley | |
| MN96FF | | Axsome Therapeutics Inc./Faktor/Long [5]/MS | - | - | call | Axsome Therapeutics Inc. | 192,931 | 192,931 | - | 19,062 % | - | Morgan Stanley | |
| MR0JY3 | | Axsome Therapeutics Inc./Faktor/Long [2]/MS | - | - | call | Axsome Therapeutics Inc. | 120,582 | 120,582 | - | 49,414 % | - | Morgan Stanley | |
| MR1XPR | | Axsome Therapeutics Inc./Faktor/Long [3]/MS | - | - | call | Axsome Therapeutics Inc. | 160,776 | 160,776 | - | 32,552 % | - | Morgan Stanley | |
| MR3HQD | | Axsome Therapeutics Inc./Faktor/Short [5]/MS | - | - | put | Axsome Therapeutics Inc. | 289,179 | 289,179 | - | 21,315 % | - | Morgan Stanley | |
| MR3JHT | | Axsome Therapeutics Inc./Faktor/Short [5]/MS | - | - | put | Axsome Therapeutics Inc. | 289,179 | 289,179 | - | 21,315 % | - | Morgan Stanley |